Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Articaine Hydrochloride, Epinephrine Bitartrate
Brand Name
Articaine Hydrochloride And Epinephrine
Generic Name
Articaine Hydrochloride, Epinephrine Bitartrate
Active Ingredient
ArticaineCategory
Other
Salt Form
Hydrochloride
Variants
2
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Articaine Hydrochloride And Epinephrine, you must consult a qualified healthcare professional.
Detailed information about Articaine Hydrochloride And Epinephrine
Articaine is a potent amide-type local anesthetic used primarily in dentistry. It is unique due to its thiophene ring and ester group, allowing for rapid metabolism and high tissue penetration.
The dosage of articaine for adults is not fixed; rather, it is determined by the dentist based on the complexity of the dental procedure, the depth of anesthesia required, and the individual patient's physical status. For most routine dental procedures in a healthy adult, the amount of articaine used typically ranges from 1.7 mL to 6.8 mL (1 to 4 cartridges).
According to the manufacturer's guidelines, the maximum recommended dose for healthy adults should not exceed 7 mg per kilogram (mg/kg) of body weight. For a standard 70 kg (154 lb) adult, this equates to a maximum of approximately 490 mg of articaine, which is roughly equivalent to 7 cartridges of the 4% solution. It is vital to note that the lowest effective dose should always be used to minimize the risk of systemic toxicity. Your dentist will carefully monitor the total volume injected, especially if the procedure is lengthy and requires supplemental injections.
Articaine is approved for use in pediatric patients aged 4 years and older. It is not recommended for children under the age of 4, as there is insufficient clinical data regarding its safety and efficacy in this age group.
For children 4 years of age and older, the dose is strictly calculated based on the child's weight, age, and the procedure's requirements. The maximum recommended dose in children is similar to adults at 7 mg/kg. However, because children have lower body weights, the total number of cartridges allowed is much smaller. For example, a child weighing 20 kg (44 lbs) would have a maximum dose of 140 mg, which is only about 2 cartridges. Dentists must exercise extreme caution to avoid accidental overdose in pediatric patients, as they are more susceptible to the central nervous system effects of local anesthetics.
Since articaine is rapidly metabolized in the plasma into an inactive metabolite (articainic acid) which is then excreted by the kidneys, patients with severe renal impairment may experience a buildup of this metabolite. While articainic acid is inactive, caution is still advised. Dose reductions are generally not required for single-dose dental procedures, but the healthcare provider should be mindful of the patient's overall kidney function if multiple doses are administered.
Although articaine is primarily metabolized by plasma esterases, a small portion is metabolized in the liver. Patients with severe hepatic (liver) disease, such as cirrhosis, may have reduced levels of plasma esterases or impaired blood flow. This can slightly slow the clearance of the drug. Healthcare providers should use the lowest effective dose and exercise caution in patients with advanced liver disease to prevent systemic accumulation.
In geriatric patients, the dose should be adjusted based on the patient's physical condition. Older adults often have a higher prevalence of cardiovascular disease and reduced organ function. Dentists typically use the 1:200,000 epinephrine formulation for elderly patients to minimize the strain on the heart and may limit the total volume of anesthetic used.
Articaine is administered exclusively by a trained dental or medical professional via submucosal injection. It is not for self-administration.
Because articaine is administered only by a healthcare provider for a specific procedure, there is no risk of a 'missed dose' in the traditional sense of a daily medication. If a procedure is interrupted and the numbness wears off, the dentist may administer a supplemental dose if it is within the safe maximum limits.
An overdose of articaine (systemic toxicity) can occur if the drug is accidentally injected directly into a blood vessel or if the maximum weight-based dose is exceeded.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
Articaine is generally well-tolerated when administered correctly, but like all medications, it can cause side effects. The most common side effects associated with articaine dental injections include:
Articaine is a safe and effective anesthetic when used by trained professionals, but several precautions must be observed. Before receiving articaine, you must inform your dentist of your full medical history, including any history of heart disease, liver disease, or allergies to medications. Because articaine contains epinephrine, it can affect blood pressure and heart rate. Furthermore, the presence of sodium metabisulfite as a preservative in the epinephrine formulation means that patients with sulfite sensitivities must be identified prior to administration.
No FDA black box warnings for Articaine. However, the FDA issued a safety communication in 2018 (updated in 2024) emphasizing the risk of methemoglobinemia associated with local anesthetic use, particularly in children under 2 and patients with certain genetic predispositions.
While there are few absolute contraindications for drug combinations with articaine, certain drugs significantly increase the risk of severe adverse reactions:
Articaine must NEVER be used in the following circumstances:
Articaine is classified as FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans. Articaine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Most dental experts recommend that if dental work is necessary, it should ideally be performed during the second trimester. Epinephrine in the formulation can theoretically reduce uterine blood flow, so the lowest effective dose should be used. There is no evidence that articaine affects fertility.
It is not known whether articaine is excreted in human milk in significant quantities. However, because articaine has an exceptionally short half-life (about 20-40 minutes), it is rapidly cleared from the mother's bloodstream. To minimize potential exposure to the nursing infant, some healthcare providers suggest that a nursing mother may choose to 'pump and dump' her milk for approximately 4 hours after receiving the injection, although many clinical guidelines suggest that the amount an infant would receive via breast milk is negligible and likely safe.
Articaine's primary molecular target is the voltage-gated sodium channel (specifically the Nav1.5 and related isoforms) on the neuronal membrane. It acts as a competitive inhibitor. The molecule exists in an equilibrium between an uncharged (lipid-soluble) form and a charged (cationic) form. The uncharged form crosses the lipid nerve membrane. Once inside the relatively acidic environment of the nerve, it becomes charged and binds to the S6 segment of domain IV of the sodium channel alpha-subunit. This binding blocks the pore, preventing sodium ion influx, which halts the depolarization required for nerve impulse propagation.
The pharmacodynamics of articaine are characterized by a rapid onset (1-3 minutes for infiltration, 4-9 minutes for block) and an intermediate duration of action. When combined with 1:100,000 epinephrine, articaine provides pulpal (tooth) anesthesia for approximately 60-75 minutes and soft tissue anesthesia for 3-5 hours. The dose-response relationship is linear up to the maximum recommended dose. Tolerance (tachyphylaxis) is not typically seen with single-use dental administration.
| Parameter | Value |
Common questions about Articaine Hydrochloride And Epinephrine
Articaine is a local anesthetic used primarily in dentistry to provide 'numbing' for various procedures. It is effective for both simple treatments, like filling a cavity, and more complex surgeries, such as tooth extractions or root canals. By blocking nerve signals in the specific area of the mouth where it is injected, it prevents the patient from feeling pain during the procedure. It is frequently chosen by dentists because it penetrates bone and tissue very effectively, often resulting in a more profound numbness than other anesthetics. Your dentist will decide if it is the right choice based on the location of the work and your health history.
The most frequent side effects of Articaine include temporary pain or soreness at the injection site, a mild headache, and slight swelling of the gums or face. These symptoms are generally mild and resolve on their own within 24 to 48 hours. Some patients may also experience a brief 'racing heart' sensation due to the epinephrine that is usually mixed with the anesthetic. While rare, some people may experience a prolonged feeling of numbness or tingling known as paresthesia. Most side effects are manageable, but you should always inform your dentist if you feel anything unusual during or after the injection.
While there is no direct chemical interaction between Articaine and alcohol, it is generally recommended that you avoid drinking alcohol for at least 24 hours after your dental procedure. Alcohol can thin the blood, which may increase the risk of bleeding or bruising at the site where the anesthetic was injected. Furthermore, if your dentist prescribes pain medication for after the procedure, alcohol could interact dangerously with those drugs. Alcohol can also dehydrate you and slow down the natural healing process of your gum tissue. It is best to wait until the numbness has completely worn off and you have finished any immediate post-operative care.
Articaine is classified as Category C by the FDA, meaning there isn't enough high-quality human data to definitively rule out risks, although animal studies have shown some concerns at high doses. Most dentists prefer to use the lowest effective dose if dental work is absolutely necessary during pregnancy, often waiting until the second trimester if possible. The main concern is the epinephrine in the injection, which could theoretically affect blood flow to the uterus if used in large amounts. However, for routine dental work, the amount of Articaine used is typically very small. Always inform your dentist if you are pregnant or planning to become pregnant so they can take the necessary precautions.
Articaine is known for its very rapid onset of action compared to many other local anesthetics. For most patients, the 'numbing' effect begins within 1 to 3 minutes if it is injected directly into the gum tissue (infiltration). If it is used for a nerve block to numb a larger area of the jaw, it may take slightly longer, usually between 4 and 9 minutes. The high lipid solubility of Articaine allows it to pass through tissue membranes quickly, which is why it works so fast. Your dentist will wait to ensure you are fully numb before beginning any part of the procedure.
Articaine is not a medication that you 'take' on a regular schedule, so the concept of stopping it suddenly does not apply. It is a one-time injection administered by a professional for a specific dental appointment. Once the procedure is over, the medication is naturally broken down by enzymes in your blood and cleared from your system within a few hours. There are no withdrawal symptoms or long-term dependency issues associated with Articaine. The numbness will gradually fade away over 3 to 5 hours, and your normal sensation will return without any special steps required on your part.
Since Articaine is only administered by a healthcare professional during a medical or dental procedure, you cannot 'miss a dose' as you would with a daily pill. If you miss a dental appointment where Articaine was going to be used, you simply reschedule the appointment. The medication is only used on an as-needed basis for pain control during the procedure itself. You do not need to take any action other than following your dentist's instructions for your rescheduled visit. If you feel that the anesthetic is wearing off too soon during a procedure, simply inform your dentist, and they can provide more if it is safe to do so.
There is no evidence to suggest that Articaine causes weight gain. It is a local anesthetic that is used once and is cleared from the body very rapidly, usually within a few hours. Because it is not a systemic medication taken over a long period, it does not have the opportunity to affect your metabolism, appetite, or fat storage. Any temporary swelling in the face or gums after the injection might be mistaken for a change in appearance, but this is due to localized inflammation, not weight gain. If you experience significant weight changes, they are likely due to other factors and should be discussed with your primary care physician.
Articaine can interact with several other types of medications, so it is crucial to give your dentist a complete list of everything you are taking. It can have serious interactions with non-selective beta-blockers, certain antidepressants (like TCAs), and MAO inhibitors, primarily because of the epinephrine in the Articaine solution. These combinations can lead to dangerous spikes in blood pressure or heart rate. Additionally, if you are taking medications that increase the risk of methemoglobinemia, such as certain 'sulfa' drugs or nitrates, your dentist needs to know. Most routine medications, like birth control or vitamins, do not interfere with Articaine, but professional screening is always required.
Yes, Articaine hydrochloride is available as a generic medication and is also sold under various brand names, the most common being Septocaine. Regardless of whether the brand name or generic version is used, the active ingredient and the concentration (usually 4%) remain the same. The generic versions must meet the same strict FDA standards for safety, strength, and quality as the original brand-name drug. Your dental office may stock either the brand or the generic, but both are considered equally effective for providing local anesthesia. You can ask your dentist which version they use if you have a specific preference.
Other drugs with the same active ingredient (Articaine)
While rare, some side effects of articaine are life-threatening and require immediate emergency care.
> Warning: Stop the procedure and call your doctor or emergency services immediately if you experience any of the following:
Articaine is designed for short-term, acute use. There are no known 'long-term' side effects from a single use of articaine in terms of systemic health. However, in very rare cases of nerve injury (paresthesia), the sensory changes can last for weeks, months, or in exceptional cases, become permanent. Studies have suggested that 4% anesthetic solutions like articaine may have a slightly higher incidence of temporary paresthesia when used for certain nerve blocks compared to 2% solutions, though this remains a topic of debate in dental research.
There are currently no FDA black box warnings for articaine hydrochloride. However, the FDA does require prominent warnings regarding the risk of methemoglobinemia for all local anesthetics, including articaine. Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or those taking certain other medications are at a higher risk for this condition.
Report any unusual symptoms to your healthcare provider.
During the procedure, the dentist will monitor your vital signs, including:
Articaine generally does not affect the central nervous system to a degree that would prevent driving. However, some patients may experience dizziness or a 'come down' effect after the dental procedure. Additionally, if the procedure was stressful or other medications (like sedatives) were used, you should wait until you feel fully alert before driving. Always consult your dentist about when it is safe to drive.
There is no direct contraindication between articaine and alcohol. However, alcohol can increase the risk of bleeding and may interact with post-operative pain medications (like ibuprofen or acetaminophen) that your dentist might prescribe. It is generally advised to avoid alcohol for at least 24 hours following a dental procedure to allow for proper healing.
As articaine is a single-use anesthetic administered for a procedure, there are no tapering requirements or withdrawal syndromes associated with its use.
> Important: Discuss all your medical conditions with your healthcare provider before starting Articaine.
Articaine does not typically interfere with standard laboratory tests. However, the presence of articaine in the blood could potentially cause a false-positive reading for certain specialized toxicology screens if performed immediately after a procedure.
For each major interaction, the mechanism involves either the cardiovascular response to epinephrine or the metabolic pathway of the anesthetic. Management strategies usually involve reducing the dose of epinephrine (using the 1:200,000 concentration) or delaying the procedure until the interacting substance has cleared the patient's system.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
There is a risk of cross-sensitivity between different amide-type local anesthetics. If you are allergic to lidocaine, there is a possibility you could be allergic to articaine. However, there is NO cross-sensitivity between amide anesthetics and 'ester' anesthetics like procaine (Novocain) or benzocaine. Your dentist may perform an allergy test if there is uncertainty.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Articaine.
Clinical studies of articaine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently than younger subjects. However, in general, elderly patients may have reduced renal or hepatic function and a higher prevalence of cardiovascular disease. For these patients, dentists often opt for the 1:200,000 epinephrine concentration and use the minimum volume necessary to achieve anesthesia.
In patients with kidney disease, the inactive metabolite articainic acid can accumulate. While this metabolite does not cause anesthesia or typical toxicity, its long-term effects in the body are not fully studied. No specific dose adjustment is usually required for a single dental visit, but caution is advised in patients on dialysis or with Stage 4-5 Chronic Kidney Disease.
Patients with severe liver disease (Child-Pugh Class C) should be treated with caution. Because a small portion of articaine is processed in the liver and because liver disease can affect the levels of enzymes in the blood that break down articaine, these patients are at a slightly higher risk for systemic toxicity. The dentist should use the lowest effective dose and monitor for signs of CNS depression.
> Important: Special populations require individualized medical assessment.
| Bioavailability | 100% (local injection) |
| Protein Binding | 60% - 80% |
| Half-life | 20 - 40 minutes |
| Tmax | 10 - 15 minutes (systemic) |
| Metabolism | Plasma Carboxylesterases (90-95%) |
| Excretion | Renal (primarily as articainic acid) |
Articaine is classified as an amide-type local anesthetic. It is grouped therapeutically with lidocaine, mepivacaine, and bupivacaine, though its specific chemical properties often lead it to be categorized as a 'hybrid' anesthetic due to its ester group.